Home › Markets › Health Care › RCEL

Avita Medical Inc. (RCEL)

RCEL trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$13.36
-0.07% on the day
Market cap
$413.2M
Small cap
Revenue · 2025
$71.6M
+11.5% on 2024
Net income · 2025
-$48.6M
-67.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerRCEL on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001762303
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$71.6M
Net income-$48.6M
Operating income-$42.5M
Net margin-67.8%
Operating margin-59.4%
Revenue growth+11.5%
Cash$10.2M
Total assets$56.4M
P/E (computed)Net income was not positive
P/S (computed)5.8×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-06-08
Latest annual report10-K2026-02-12
Latest quarterly / interim10-Q2026-08-06
Latest current report8-K2026-08-11
Latest proxyDEF 14A2026-04-22

Source: SEC EDGAR submissions feed, 375 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.7%
1 month+28.6%
3 months+163.8%
Year to date+280.7%
1 year+151.1%
From 52-week high-1.8%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
CARLCarlsmed Inc.$14.47-2.10%$395.1M
NPCENeuropace Inc.$12.68-2.46%$435.2M
OFIXOrthofix Medical Inc. Common Stock (DE)$9.26-0.22%$377.2M
SIShoulder Innovations Inc.$18.07-0.88%$376.2M
CERSCerus Corporation$2.260.00%$455.4M
ANGOAngioDynamics Inc.$10.90-4.39%$458.4M
SGHTSight Sciences Inc.$8.39-6.41%$462.2M
SENSSenseonics Holdings Inc.$8.92-3.46%$471.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier